FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy

Disclosure: B. Olenchock: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. S. Podgrabinska: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. C. Hou: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron...

Descripción completa

Detalles Bibliográficos
Autores principales: Olenchock, Ben, Podgrabinska, Simona, Hou, Christine, Musser, Bret, Mendell, Jeanne, Harman, Amy, Sanchez, Robert J, Miller, Kathryn, Parasoglou, Prodromos, Hectors, Stefanie, Karnik, Satyajit, Pagovich, Odelya E, SinhaRoy, Ranabir, Harris, Charles A, Akinci, Baris, Simsir, Ilgin Yildirim, Ozen, Samim, Sorkina, Ekaterina, Garg, Abhimanyu, Vargas Gonzalez, Rolando Jesus, Weinreich, David M, Herman, Gary, Oral, Elif A, Brown, Rebecca J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553570/
http://dx.doi.org/10.1210/jendso/bvad114.069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553570/
http://dx.doi.org/10.1210/jendso/bvad114.069

Ejemplares similares